Enantioselective Radical Conjugate Additions
) 8.5 Hz, 2H), 5.59 and 5.57 (2d, J ) 10.0 and 10.5 Hz, 1H),
4.46 and 4.20 (dd and d, J ) 5.5, 15 Hz and 6.0 Hz, 1H), 4.45
and 4.20 (dd and d, J ) 6.0, 12.5 Hz and 6.0 Hz, 1H), 3.81 and
3.77 (2s, 3H), 3.50 and 3.44 (2dd, J ) 5.0, 11 Hz and 5.0, 10.0
Hz, 1H), 2.08-2.00 and 1.98-1.92 (2m, 1H), 0.94 and 0.90 (2d,
J ) 8.0 Hz, 3H), 0.91 (d, J ) 8.5 Hz, 3H); 13C NMR (CDCl3,
125 MHz) δ 162.9 and 162.2, 159.4, 137.0 and 136.9, 130.9
and 130.3, 129.1 and 128.8 (2C), 128.1, 127.9 and 127.85 (2C),
127.80 (2C), 126.8 and 126.2, 114.0 and 113.9, 93.1 and 92.9,
55.4, 54.0 and 53.3, 44.2 and 44.0, 29.5 and 28.9, 21.8 and 21.3,
18.2 and 17.6; IR (film) νmax 3259, 1659, 1552 cm-1; HRMS
(FAB) m/z 379.1647 (MNa+, C20H24N2O4Na requires 379.1634).
N-Benzyl-4-methyl-2-nitro-3-phenylpentanamide (7b).
Prepared with Zn(OTf)2 as Lewis acid, obtained as an 84:16
mixture with 8b in 84% combined yield, and isolated as a 1:1
mixture of diastereomers: 1H NMR (CDCl3, 500 MHz) δ 7.36-
7.24 (m, 6H), 7.20 (d, J ) 10.5 Hz, 2H), 7.10 and 6.79 (2d, J )
7.0 and 8.0 Hz, 2H), 6.85 and 6.37 (2br s, 1H), 5.64 and 5.62
(2d, J ) 7.5 and 10.5 Hz, 1H), 4.51-4.41 (m, 1H), 4.25-4.15
(m, 1H), 3.57-3.50 (m, 1H), 2.12-2.04 and 2.03-1.97 (2m, 1H),
0.98-0.85 (m, 6H); 13C NMR (CDCl3, 125 MHz) δ 162.8 and
162.1, 137.0 and 136.8, 134.9 and 134.5, 129.9 and 129.3, 129.1
and 128.8 (2C), 128.7, 128.6 and 128.5 (2C), 128.18 and 128.10,
127.9 and 127.7, 128.0 and 127.8 (2C), 93.0 and 92.8, 54.4 and
54.0, 44.3 and 44.0, 29.5 and 28.9, 21.8 and 21.3, 18.1 and 17.7;
IR (film) νmax 3221, 1650, 1564 cm-1; HRMS (FAB) m/z
327.1704 (MH+, C19H22N2O3H requires 327.1709).
and 5.11 (s, 2H), 5.00 (br s, 1H), 4.99 and 4.84 (2d, J ) 6 and
9.5 Hz, 1H), 4.86 and 4.82 (2dd, J ) 6.5, 9.0 Hz, 1H), 3.78 (s,
3H), 3.65 and 3.63 (2s, 3H), 2.84-2.79 and 2.62-2.58 (2m, 1H),
2.26-2.20 and 2.09-2.02 (2m, 1H), 1.26-1.19 and 0.79-0.72
(m, 6H); 13C NMR (CDCl3, 125 MHz) δ 172.7 and 171.7, 158.9,
156.8 and 155.9, 136.5 and 136.4, 130.5, 130.1 (2C), 129.7 (2C),
128.8 and 128.7, 128.4 and 128.3 (2C), 127.9 and 127.2, 114.2
and 113.9, 67.3 and 67.1, 56.2 and 56.0, 55.3, 54.5, 52.3 and
52.1, 29.9 and 29.0, 21.5, 21.1; IR (film) νmax 3346, 2959, 1726,
1602, 1222, 1048 cm-1; HRMS (FAB) m/z 386.1975 (MH+,
C22H27NO5H requires 386.1967).
syn-9a was obtained in 21% ee, as analyzed by HPLC
(Chiralcel OD-H, 98:2 hexane/i-PrOH, 1 mL/min; tR ) 16.9 min
(major), 27.3 min). anti-9a was obtained in 28% ee, as analyzed
by HPLC under identical conditions (tR ) 11.4 min (major),
25.2 min).
Methyl 2-Benzyloxycarbonylamino-2-deuterio-3-(4-
methoxyphenyl)-4-methylpentanoate (d-9a). (Produced by
combination of the general procedure for radical conjugate
additions to esters promoted by achiral Lewis acids with the
reduction and protection protocols contained in the chiral
Lewis acid general procedure.) 1H NMR (CDCl3, 500 MHz) was
identical to 9a except for the absence of the two signals at δ
4.99 and 4.84. Also, the multiplets at δ 2.84-2.79 and 2.62-
2.58 appeared as two doublets centered at δ 2.82 and 2.61
(J ) 10.0 and 10.5 Hz). HRMS (FAB) m/z 387.2018 (M+,
C22H26DNO5H requires 387.2012).
N-Benzyl 2-benzyloxycarbonylamino-3-(4-methoxy-
phenyl)-4-methylpentanamide (10a) (76% yield, 1.4:1 syn/
anti): 1H NMR (CDCl3, 500 MHz) δ 7.37-7.24 (m, 7H), 7.17
(d, J ) 10.5 Hz, 2H), 7.05 (dd, J ) 8.5, 14.5 Hz, 2H), 6.81-
6.73 (m, 3H), 6.25 and 6.01 (2 br s, 1H) 5.35 and 4.97 (2d, J )
7.0 and 5.5 Hz, 1H), 5.12 and 5.09 (2s, 2H), 4.72 and 4.61 (2t,
J ) 4.5 and 9.5 Hz, 1H), 4.45-4.24 and 4.37 (m and dd, J )
7.0, 15.5 Hz, 1H), 4.03 (dd, J ) 4.5, 15.5 Hz, 1H), 3.87 (s, 3H),
3.19-3.08 and 2.87-2.77 (2m, 1H), 2.38-2.22 and 2.10-1.94
(2m, 1H), 1.05 and 0.91 (2d, J ) 6.0 Hz, 3H), 0.80 and 0.77
(2d, J ) 6.2 Hz, 3H); 13C NMR (CDCl3, 125 MHz) δ 170.6,
159.4, 156.3, 138.4 and 137.5, 136.3 (2C), 129.8, 128.79 and
128.72 (2C), 128.5 (2C), 128.4, 128.36, 128.32 (2C), 127.8,
127.6, 127.4 and 127.3 (2C), 113.7, 67.4, 57.2, 55.7 and 55.6,
54.8 and 53.4, 43.5, 28.5, 21.7, 18.7; IR (film) νmax 3281, 2930,
1649, 1520 cm-1; HRMS (FAB) m/z 483.2252 (MNa+, C28H32N2-
O4Na requires 483.2260).
syn-10a was obtained in 88% ee, as analyzed by HPLC
(Chiralcel OD-H, 98:2 hexane/i-PrOH, 1 mL/min; tR ) 20.3 min
(major), 27.8 min). anti-10a was obtained in 76% ee, as
analyzed by HPLC under identical conditions (tR ) 27.6 min
(major), 38.4 min).
N-Benzyl 2-Benzyloxycarbonylamino-2-deuterio-3-(4-
methoxyphenyl)-4-methylpentanamide (d-10a). (Pro-
duced by combination of the General Procedure for radical
conjugate additions to amides promoted by achiral Lewis acids
with the reduction and protection protocols contained in the
chiral Lewis acid general procedure.) 1H NMR (CDCl3, 500
MHz) was identical to 10a except for the absence of the signals
at δ 4.72 and 4.61. Also, the two multiplets at δ 3.19-3.08
and 2.87-2.77 appeared as two doublets centered at δ 3.11
and 2.80 (J ) 8.5 and 9.0 Hz). HRMS (FAB) m/z 484.2308
(MNa+, C28H31DN2O4Na requires 484.2322).
General Procedure for Radical Conjugate Additions
Promoted by Chiral Lewis Acid. A solution of Mg(NTf2)2
(116.9 mg, 0.20 mmol) and ligand 14a (91.7 mg, 0.20 mmol)
in anhydrous CH2Cl2 (1.5 mL) was stirred at rt for 1-2 h and
then treated with Z-1 or E-6 (0.20 mmol). The walls of the
reaction vessel were washed with CH2Cl2 (0.5 mL), and the
mixture was stirred at -78 °C for 30 min. Alkyl iodide (1.0
mmol), Bu3SnH (134 µL, 145 mg, 0.50 mmol), Et3B (3.45 M
solution in CH2Cl2, 290 µL, 1.0 mmol), and O2 (10 mL) were
added sequentially, and identical quantities of these reagents
were added twice more at 1.5 h intervals. The mixture was
stirred at -78 °C for an additional 1.5 h (4.5 h total since
initiation of radical reaction), treated with 2 N HCl (10 mL),
and extracted with CH2Cl2 (2 × 10 mL). The combined organic
layers were concentrated in vacuo.
The crude adduct 2 or 7 was treated with concd HCl (0.60
mL, 7.2 mmol), H2O (3 mL), THF (3 mL), and indium powder
(184 mg, 1.6 mmol). The resulting mixture was stirred at rt
for 12 h, the solids were removed, and the volatiles were
removed in vacuo. The residue was diluted with 1 N HCl (10
mL), and tin byproducts were removed by extraction with
hexanes (3 × 10 mL). The aqueous layer was treated with Na2-
CO3 (added until pH ≈ 8) and satd aq sodium potassium
tartrate solution (10 mL) and then extracted with CH2Cl2 (3
× 20 mL). The combined organic layers were dried (Na2SO4)
and concentrated in vacuo. Thirty percent of the crude amine
mixture was subjected to flash chromatography (SiO2, 25-60%
EtOAc in hexanes gradient elution for amines derived from 2
or 1-4% MeOH in CH2Cl2 gradient elution for amines derived
from 7) to afford samples of the pure syn and anti diastereo-
mers suitable for chiral HPLC analysis after further deriva-
tization.
The remaining 70% of the crude amine mixture was treated
with benzyl chloroformate (22.8 µL, 27.6 mg, 0.15 mmol), Na2-
CO3 (16.3 mg, 0.15 mmol), and THF (3 mL). The resulting
mixture was stirred at rt for 12 h, concentrated in vacuo, and
purified by flash chromatograghy (SiO2, 7-13% EtOAc in
hexanes gradient elution for carbamates derived from 2 or 20-
30% EtOAc in hexanes gradient elution for carbamates derived
from 7), affording carbamates 9 or 10 as white solids that were
mixtures of diastereomers.
Acknowledgment. We thank Brigham Young Uni-
versity and the National Institutes of Health (GM70483)
for financial support and Dr. John F. Cannon for
performing X-ray crystallography.
Supporting Information Available: General experimen-
tal details, synthetic procedures, spectral data, and 1H and
13C NMR spectra for all new compounds. This material is
Methyl
2-benzyloxycarbonylamino-3-(4-methoxy-
phenyl)-4-methylpentanoate (9a) (75% yield, 2.6:1 syn/
anti): 1H NMR (CDCl3, 500 MHz) δ 7.38-7.34 (m, 5H), 6.98
and 6.94 (2d, J ) 9.0 and 8.5 Hz, 2H), 6.84-6.81 (m, 2H), 5.14
JO051334F
J. Org. Chem, Vol. 70, No. 20, 2005 8147